The Occurrence of Thrombosis during Intensive Chemotherapy Treatment for Acute Myeloid Leukemia Patients Does Not Impact on Long-Term Survival

被引：0
|
作者：
Hellou, Tamer [1 ]
Cohen, Omri [2 ]
Avigdor, Abraham [3 ]
Shimoni, Avichai [4 ]
Misgav, Mudi [2 ,5 ]
Canaani, Jonathan [6 ]
机构：
[1] Sheba Med Ctr, Tel Hashomer, Israel
[2] Sheba Med Ctr, Natl Hemophilia Ctr, Tel Hashomer, Israel
[3] Chaim Sheba Med Ctr, Ramat Gan, Israel
[4] Chaim Sheba Med Ctr, Div Hematol & Bone Marrow Transplantat, Ramat Gan, Israel
[5] Sheba Med Ctr, Inst Thrombosis & Hemostasis, Tel Hashomer, Israel
[6] Sheba Med Ctr, Hematol Div, Giv'atayim, Israel
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-156099
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3229 / 3230
页数：2
相关论文
共 50 条
  • [1] The occurrence of thrombosis during intensive chemotherapy treatment for acute myeloid leukemia patients does not impact on long-term survival
    Hellou, Tamer
    Cohen, Omri
    Avigdor, Abraham
    Amitai, Irina
    Shimoni, Avichai
    Misgav, Mudi
    Canaani, Jonathan
    ANNALS OF HEMATOLOGY, 2023, 102 (05) : 1037 - 1043
  • [2] The occurrence of thrombosis during intensive chemotherapy treatment for acute myeloid leukemia patients does not impact on long-term survival
    Tamer Hellou
    Omri Cohen
    Abraham Avigdor
    Irina Amitai
    Avichai Shimoni
    Mudi Misgav
    Jonathan Canaani
    Annals of Hematology, 2023, 102 : 1037 - 1043
  • [3] TREATMENT OF ACUTE MYELOID-LEUKEMIA WITH A COMBINATION OF INTENSIVE INDUCTION CHEMOTHERAPY, EARLY CONSOLIDATION, SPLENECTOMY AND LONG-TERM MAINTENANCE CHEMOTHERAPY
    MACHOVER, D
    RAPPAPORT, H
    SCHWARZENBERG, L
    MISSET, JL
    GOLDSCHMIDT, E
    LEMAIGRE, G
    DORVAL, T
    DEVASSAL, F
    GAGET, H
    ANTICANCER RESEARCH, 1985, 5 (06) : 633 - 633
  • [4] TREATMENT OF ACUTE MYELOID-LEUKEMIA WITH A COMBINATION OF INTENSIVE INDUCTION CHEMOTHERAPY, EARLY CONSOLIDATION, SPLENECTOMY AND LONG-TERM MAINTENANCE CHEMOTHERAPY
    MACHOVER, D
    RAPPAPORT, H
    SCHWARZENBERG, L
    MISSET, JL
    GOLDSCHMIDT, E
    LEMAIGRE, G
    DORVAL, T
    DEVASSAL, F
    RIBAUD, P
    GAGET, H
    MATHE, G
    CANCER, 1984, 53 (08) : 1644 - 1650
  • [5] Prediction of survival with intensive chemotherapy in acute myeloid leukemia
    Sasaki, Koji
    Ravandi, Farhad
    Kadia, Tapan
    DiNardo, Courtney
    Borthakur, Gautam
    Short, Nicholas
    Jain, Nitin
    Daver, Naval
    Jabbour, Elias
    Garcia-Manero, Guillermo
    Khoury, Joseph
    Konoplev, Sergej
    Loghavi, Sanam
    Patel, Keyur
    Montalban-Bravo, Guillermo
    Masarova, Lucia
    Konopleva, Marina
    Kantarjian, Hagop
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (07) : 865 - 876
  • [6] LONG-TERM RESULTS OF INTENSIVE CHEMOTHERAPY OF ACUTE MYELOGENOUS LEUKEMIA
    FOON, K
    ZIGHELBOIM, J
    GALE, RP
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 361 - 361
  • [7] Long-term survival after chemotherapy for acute myeloid leukemia - The experience of the Southwest Oncology Group
    Appelbaum, FR
    Kopecky, KJ
    CANCER, 1997, 80 (11) : 2199 - 2204
  • [8] Long-term outcome of high risk patients with myelodysplastic syndromes or secondary acute myeloid leukemia receiving intensive chemotherapy
    Esther Schuler
    Natalie Zadrozny
    Sabine Blum
    Thomas Schroeder
    Corinna Strupp
    Barbara Hildebrandt
    Andrea Kündgen
    Norbert Gattermann
    Carlo Aul
    Mustafa Kondakci
    Guido Kobbe
    Rainer Haas
    Ulrich Germing
    Annals of Hematology, 2018, 97 : 2325 - 2332
  • [9] Long-term outcome of high risk patients with myelodysplastic syndromes or secondary acute myeloid leukemia receiving intensive chemotherapy
    Schuler, Esther
    Zadrozny, Natalie
    Blum, Sabine
    Schroeder, Thomas
    Strupp, Corinna
    Hildebrandt, Barbara
    Kuendgen, Andrea
    Gattermann, Norbert
    Aul, Carlo
    Kondakci, Mustafa
    Kobbe, Guido
    Haas, Rainer
    Germing, Ulrich
    ANNALS OF HEMATOLOGY, 2018, 97 (12) : 2325 - 2332
  • [10] Long-term survival can be achieved in a significant fraction of older patients with core-binding factor acute myeloid leukemia treated with intensive chemotherapy
    Mosna, Federico
    Borlenghi, Erika
    Litzow, Mark
    Byrd, John C.
    Papayannidis, Cristina
    Tecchio, Cristina
    Ferrara, Felicetto
    Marcucci, Guido
    Cairoli, Roberto
    Morgan, Elizabeth A.
    Gurrieri, Carmela
    Yeung, Cecilia C. S.
    Deeg, H. Joachim
    Capelli, Debora
    Candoni, Anna
    Gotlib, Jason R.
    Lunghi, Monia
    Pullarkat, Sheeja
    Lanza, Francesco
    Galimberti, Sara
    Forghieri, Fabio
    Venditti, Adriano
    Festuccia, Moreno
    Audisio, Ernesta
    Marvalle, Denise
    Rigolin, Gian Matteo
    Roti, Giovanni
    Dibona, Eros
    Visani, Giuseppe
    Albano, Francesco
    Eisfeld, Ann-Kathrin
    Valent, Peter
    Huls, Gerwin
    Borthakur, Gautam
    Krampera, Mauro
    Martinelli, Giovanni
    Kroeger, Nicolaus
    Sperotto, Alessandra
    Gottardi, Michele
    HAEMATOLOGICA, 2025, 110 (03) : 608 - 620
12345